These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 28753783)

  • 1. Gene Expression Profiling of Advanced Penile Squamous Cell Carcinoma Receiving Cisplatin-based Chemotherapy Improves Prognostication and Identifies Potential Therapeutic Targets.
    Necchi A; Eigl BJ; Yang ES; Bae S; Chandrashekar D; Chen D; Naik G; Mehta A; Giannatempo P; Colecchia M; Gordetsky J; Wei S; Cooper T; Varambally S; Sonpavde G
    Eur Urol Focus; 2018 Sep; 4(5):733-736. PubMed ID: 28753783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic risk stratification derived from individual patient level data for men with advanced penile squamous cell carcinoma receiving first-line systemic therapy.
    Pond GR; Di Lorenzo G; Necchi A; Eigl BJ; Kolinsky MP; Chacko RT; Dorff TB; Harshman LC; Milowsky MI; Lee RJ; Galsky MD; Federico P; Bolger G; DeShazo M; Mehta A; Goyal J; Sonpavde G
    Urol Oncol; 2014 May; 32(4):501-8. PubMed ID: 24332646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Factors of Adjuvant Taxane, Cisplatin, and 5-Fluorouracil Chemotherapy for Patients With Penile Squamous Cell Carcinoma After Regional Lymphadenectomy.
    Necchi A; Lo Vullo S; Nicolai N; Raggi D; Giannatempo P; Colecchia M; Catanzaro M; Torelli T; Piva L; Biasoni D; Stagni S; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Dec; 14(6):518-523. PubMed ID: 27050716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neoadjuvant docetaxel, cisplatin and ifosfamide (ITP) combination chemotherapy for treating penile squamous cell carcinoma patients with terminal lymph node metastasis.
    Xu J; Li G; Zhu SM; Cai QL; Wang Z; Yang X; Zhang HT; Niu YJ
    BMC Cancer; 2019 Jun; 19(1):625. PubMed ID: 31238987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study.
    Sharma P; Djajadiningrat R; Zargar-Shoshtari K; Catanzaro M; Zhu Y; Nicolai N; Horenblas S; Spiess PE
    Urol Oncol; 2015 Nov; 33(11):496.e17-23. PubMed ID: 26072110
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II study of docetaxel, cisplatin, and fluorouracil in patients with distantly metastatic penile cancer as first-line chemotherapy.
    Zhang S; Zhu Y; Ye D
    Oncotarget; 2015 Oct; 6(31):32212-9. PubMed ID: 26311739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Panitumumab Treatment for Advanced Penile Squamous Cell Carcinoma When Surgery and Chemotherapy Have Failed.
    Necchi A; Giannatempo P; Lo Vullo S; Raggi D; Nicolai N; Colecchia M; Perrone F; Mariani L; Salvioni R
    Clin Genitourin Cancer; 2016 Jun; 14(3):231-6. PubMed ID: 26362073
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma.
    Pond GR; Milowsky MI; Kolinsky MP; Eigl BJ; Necchi A; Harshman LC; Di Lorenzo G; Dorff TB; Lee RJ; Sonpavde G
    Clin Genitourin Cancer; 2014 Dec; 12(6):440-6. PubMed ID: 24787971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection of a patient subgroup with advanced esophageal squamous carcinoma who could benefit from second-line chemotherapy.
    Kim ST; Park KH; Oh SC; Seo JH; Shin SW; Kim JS; Kim YH
    Oncology; 2010; 79(5-6):363-9. PubMed ID: 21430405
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis.
    Di Lorenzo G; Buonerba C; Federico P; Perdonà S; Aieta M; Rescigno P; D'Aniello C; Puglia L; Petremolo A; Ferro M; Marinelli A; Palmieri G; Sonpavde G; Mirone V; De Placido S
    BJU Int; 2012 Dec; 110(11 Pt B):E661-6. PubMed ID: 22958571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First-line therapy with dacomitinib, an orally available pan-HER tyrosine kinase inhibitor, for locally advanced or metastatic penile squamous cell carcinoma: results of an open-label, single-arm, single-centre, phase 2 study.
    Necchi A; Lo Vullo S; Perrone F; Raggi D; Giannatempo P; Calareso G; Nicolai N; Piva L; Biasoni D; Catanzaro M; Torelli T; Stagni S; Togliardi E; Colecchia M; Busico A; Gloghini A; Testi A; Mariani L; Salvioni R
    BJU Int; 2018 Mar; 121(3):348-356. PubMed ID: 28921872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Genomic Profiling of Advanced Penile Carcinoma Suggests a High Frequency of Clinically Relevant Genomic Alterations.
    Ali SM; Pal SK; Wang K; Palma NA; Sanford E; Bailey M; He J; Elvin JA; Chmielecki J; Squillace R; Dow E; Morosini D; Buell J; Yelensky R; Lipson D; Frampton GM; Howley P; Ross JS; Stephens PJ; Miller VA
    Oncologist; 2016 Jan; 21(1):33-9. PubMed ID: 26670666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trajectories of squamous cell carcinoma antigen and outcomes of patients with advanced penile cancer after chemotherapy based on paclitaxel, ifosfamid, and cisplatin regimen.
    Ma N; Gan YX; Chao YY; Liu ZH; Chen XD; Yao K; Han H; Guo SJ
    Cancer Med; 2024 Jun; 13(12):e7353. PubMed ID: 38888362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chemotherapy with cisplatin and 5-fluorouracil for penile and urethral squamous cell carcinomas.
    Hussein AM; Benedetto P; Sridhar KS
    Cancer; 1990 Feb; 65(3):433-8. PubMed ID: 2297633
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taxanes in combination with cisplatin and fluorouracil for advanced penile cancer: preliminary results.
    Pizzocaro G; Nicolai N; Milani A
    Eur Urol; 2009 Mar; 55(3):546-51. PubMed ID: 18649992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatin, methotrexate and bleomycin for treating advanced penile carcinoma.
    Hakenberg OW; Nippgen JB; Froehner M; Zastrow S; Wirth MP
    BJU Int; 2006 Dec; 98(6):1225-7. PubMed ID: 17125480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study.
    Mollica V; Massari F; Maruzzo M; Bimbatti D; Claps M; Maiorano BA; Vitale MG; Iacovelli R; Ermacora P; Roviello G; Calabrò F; Caffo O; Vignani F; Grillone F; Pierantoni F; Di Napoli M; Mennitto A; Marchetti A; Mattana A; Cavo A; Bassanelli M; Formisano L; Prati V; Giudice GC; Buti S
    Clin Genitourin Cancer; 2024 Jun; 22(3):102074. PubMed ID: 38616147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical Outcomes of Perioperative Chemotherapy in Patients With Locally Advanced Penile Squamous-Cell Carcinoma: Results of a Multicenter Analysis.
    Necchi A; Pond GR; Raggi D; Ottenhof SR; Djajadiningrat RS; Horenblas S; Khoo V; Hakenberg OW; Draeger D; Protzel C; Heidenreich A; Haidl F; Eigl BJ; Nappi L; Matsumoto K; Vaishampayan U; Woods ME; Salvioni R; Nicolai N; Catanzaro M; Giannatempo P; Geynisman DM; Preto M; Xylinas E; Milowsky MI; De Placido S; Di Lorenzo G; Sonpavde G
    Clin Genitourin Cancer; 2017 Oct; 15(5):548-555.e3. PubMed ID: 28325636
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dramatic response of penile cancer with inguinal lymph node metastases to neoadjuvant chemotherapy with paclitaxel, ifosfamide and cisplatin : a case report].
    Kubota Y; Nakano M; Nagai S; Matsuoka K; Arakawa H; Horie K; Deguchi T; Kato H
    Hinyokika Kiyo; 2015 Jan; 61(1):33-7. PubMed ID: 25656018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metastatic penile squamous cell carcinoma with dramatic response to combined checkpoint blockade with ipilimumab and nivolumab.
    Baweja A; Mar N
    J Oncol Pharm Pract; 2021 Jan; 27(1):212-215. PubMed ID: 32380900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.